1292476

Regeneron Pharmaceuticals Inc — FEI 1000521995

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 10, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Tarrytown, NY (United States)

Additional Details

Bioanalytical BA/BE